EASTON BIOPHARMACEUTICALS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EASTON BIOPHARMACEUTICALS Trademark

Serial Number: 97571459 • Registration: 7436252

EASTON BIOPHARMACEUTICALS is a trademark filed by Chengdu Easton Biopharmaceuticals Co., Ltd. on August 30, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Chengdu Easton Biopharmaceuticals Co., Ltd. (2 trademarks)

NO. 8, XIYUAN AVENUE
CHENGDU HIGH TECH ZONE 610000 , CN

Entity Type: 99

Trademark Details

Filing Date

August 30, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Antidotes; Analgesic preparations; Anti-sarcoma preparations; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention of neurological diseases; General anesthetics; Medicinal infusions for treating diabetes; Nasal spray preparations; Nasal sprays for medical purposes; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical products for the prevention and treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceuticals, namely, psychotropics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2024 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 14, 2024 ZZZX
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 8, 2023 JURT
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Aug 8, 2023 ISPO
44(e) PETITION - DISMISSED
Aug 8, 2023 44EM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
ASSIGNED TO PETITION STAFF
Aug 1, 2023 APET
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
44(e) PETITION - RECEIVED
Jul 18, 2023 44EP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 18, 2023 EPPA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2023 CNSA
ASSIGNED TO EXAMINER
Jun 15, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 20, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2022 NWOS
NEW APPLICATION ENTERED
Sep 2, 2022 NWAP